{
  "id": 3446,
  "text": "1412.Onishi, H., et al.Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical treated with radical radiation therapy.The Cancer journal from Scientific American 5, 40-45 (1999).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1412.Onishi, H., et al.Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical treated with radical radiation therapy.The Cancer journal from Scientific American 5, 40-45 (1999).\n\n<question>: ",
  "ChatGPT_response_0": "在确定哪些宫颈癌Ⅲ或Ⅳ期患者适合接受动脉内注射铂类药物的治疗方案时，临床医生通常会综合考虑患者的病情严重程度、身体状况、年龄、肿瘤大小、淋巴结转移情况等因素。通常来说，接受根治性放射治疗后疗效不佳或容易出现复发的患者可能会被考虑接受这种治疗方案。此外，临床医生还会根据患者的个体情况和身体状况进行全面评估，以确定最合适的治疗方案。因此，在决定是否采用动脉内注射铂类药物治疗时，应该由专业医生根据患者的具体情况做出综合判断和指导。",
  "query": "这项研究中提到了通过动脉内注入铂类药物对接受根治性放射治疗的宫颈癌Ⅲ或Ⅳ期患者的影响。在临床实践中，如何确定哪些患者适合接受这种治疗方案？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这项研究中提到了通过动脉内注入铂类药物对接受根治性放射治疗的宫颈癌Ⅲ或Ⅳ期患者的影响。在临床实践中，如何确定哪些患者适合接受这种治疗方案？\n\n<reference text>: 1412.Onishi, H., et al.Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical treated with radical radiation therapy.The Cancer journal from Scientific American 5, 40-45 (1999).\n\n<reply>: ",
  "response": "在确定哪些宫颈癌Ⅲ或Ⅳ期患者适合接受动脉内注射铂类药物的治疗方案时，临床医生通常会综合考虑患者的病情严重程度、身体状况、年龄、肿瘤大小、淋巴结转移情况等因素。通常来说，接受根治性放射治疗后疗效不佳或容易出现复发的患者可能会被考虑接受这种治疗方案。此外，临床医生还会根据患者的个体情况和身体状况进行全面评估，以确定最合适的治疗方案。因此，在决定是否采用动脉内注射铂类药物治疗时，应该由专业医生根据患者的具体情况做出综合判断和指导。"
}